{
    "title": "109_hr3955",
    "content": "The \"Meth Lab Eradication Act\" is the short title of this Act. It involves transferring ephedrine, pseudoephedrine, and phenylpropanolamine to Schedule V, with an exception for list I pseudoephedrine products. The \"Meth Lab Eradication Act\" transfers ephedrine, pseudoephedrine, and phenylpropanolamine to Schedule V, with an exception for certain pseudoephedrine products. The \"Meth Lab Eradication Act\" transfers ephedrine, pseudoephedrine, and phenylpropanolamine to Schedule V, with an exception for certain pseudoephedrine products that are approved under section 505 of the Federal Food, Drug, and Cosmetic Act. Amendments are made to the Controlled Substances Act regarding List I chemicals, including the removal of provisions related to ephedrine and phenylpropanolamine. Amendments to the Controlled Substances Act include redefining pseudoephedrine products and removing provisions related to ephedrine and phenylpropanolamine. Amendments to the Controlled Substances Act involve removing subparagraphs, redesignating clauses, and regulating transactions involving listed chemicals in drugs marketed lawfully in the US under the Federal Food, Drug, and Cosmetic Act. The amendments to the Controlled Substances Act involve regulating transactions involving listed chemicals in drugs to prevent diversion for illicit production of controlled substances. SEC. 3. REQUIREMENTS REGARDING LIST I PSEUDOEPHEDRINE PRODUCTS. Section 310 of the Controlled Substances Act is amended to include requirements for retail sales of list I pseudoephedrine products, such as placing the product behind-the-counter and delivering it directly to the purchaser. The Controlled Substances Act now includes regulations for retail sales of list I pseudoephedrine products, requiring them to be kept behind the counter and sold directly to customers. Sellers must adhere to specific conditions, including not selling products that can be further divided, limiting sales to one per person per day, maintaining a logbook of sales, and ensuring that buyers are at least 18 years old. To purchase list I pseudoephedrine products, individuals must be 18 or older, show a government-issued ID with a photo, sign a logbook with their name, address, date, and time of sale. Sellers must verify the information matches the ID and keep possession of each sale. The person must keep possession of each logbook for at least two years after the last sale, not offer free products with a purchase, and post a notice about purchasing limits for pseudoephedrine products on the premises. The purchase of pseudoephedrine products requires signing a logbook accessible to law enforcement. The Attorney General can require reports on suspicious transactions related to these products. The Attorney General can require reports on suspicious transactions involving pseudoephedrine products, including transactions with specific individuals or organizations and any unusual loss of supplies. Manufacturers and wholesale distributors may also be required to report transactions involving extraordinary quantities of the product. The Attorney General can require reports on suspicious transactions involving pseudoephedrine products, including transactions with specific individuals or organizations and any unusual loss of supplies. Manufacturers and wholesale distributors may also be required to report transactions involving an extraordinary quantity of the product. Certain regulations apply to these transactions, and there is a removal of an exception regarding the status as a list I chemical. The Attorney General may remove the exception for list I pseudoephedrine products if they are being diverted for illicit methamphetamine production. This authority is in addition to the existing authority under section 204. SEC. 4. REQUIREMENTS REGARDING SCHEDULE V METHAMPHETAMINE-RELATED PRODUCTS. Amendment to the Controlled Substances Act requires pharmacies to follow specific regulations for the sale of schedule V methamphetamine-related products without prescriptions. This amendment aligns the sale of these products with the requirements for list I pseudoephedrine products. The Controlled Substances Act is amended to include regulations for the sale of schedule V methamphetamine-related products without prescriptions, aligning them with list I pseudoephedrine products. The Controlled Substances Act is amended to include regulations for the sale of schedule V pseudoephedrine products without prescriptions. SEC. 5. ENFORCEMENT. Sales at Retail of Methamphetamine-Related Products: Section 402 of the Controlled Substances Act is amended to include restrictions on retail distributors selling methamphetamine-related products. The Controlled Substances Act is amended to include restrictions on retail distributors selling methamphetamine-related products, including penalties for violations such as knowingly or negligently selling pseudoephedrine products or failing to submit required reports. The Controlled Substances Act is amended to include restrictions on retail distributors selling methamphetamine-related products, with penalties for violations related to pseudoephedrine products. Amendments include changes to subsections (b)(3) and (f) to align with section 402(a)(13) and (12) respectively, and specify exceptions in subsection (d)(2). Amendments to the Controlled Substances Act impose restrictions on retail purchases of pseudoephedrine products, with penalties for violating logbook requirements. It is unlawful to purchase more than one schedule V or list I pseudoephedrine product in a 24-hour period, or more than 7,500 milligrams in a 30-day period without a prescription. Additionally, purchasing methamphetamine-related products without signing the appropriate logbook is prohibited. Amendments to the Controlled Substances Act now include penalties for possession or distribution of specified substances without authorization. Penalties apply for knowingly distributing or dispensing controlled substances for unauthorized manufacturing purposes. Penalties for distributing schedule V(b) controlled substances without authorization include fines or imprisonment for up to 5 years under title 18, United States Code. SEC. 6. IMPORTS. Amends the Controlled Substances Import and Export Act to include ephedrine, pseudoephedrine, and phenylpropanolamine in the list of controlled substances."
}